News & Topics

HOME > News & Topics > Research > FY 2017 > The activated conformation of integrin β7 is a novel multiple myeloma-specific target for CAR T cell therapy(Kumanogoh Group, in Nature Medicine)

The activated conformation of integrin β7 is a novel multiple myeloma-specific target for CAR T cell therapy(Kumanogoh Group, in Nature Medicine)

Professor Kumanogoh and his research group showed the active conformer of an integrin can serve as a specific therapeutic target for multiple myeloma.



 
Commentary (PDF)


Article (External Link)


Contact:
Naoki Hosen

Naoki Hosen

Dept. of Cancer Stem Cell Biology
Osaka Univ. Graduate School of Medicine

Tel06-6879-3676
FAX 06-6879-3677
Mail hnaokiimed3.med.osaka-u.ac.jp

Archives

 
TOPに戻る